09:40 AM EDT, 05/06/2025 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) reported a Q1 net loss Tuesday of $0.82 per diluted share.

Analysts polled by FactSet expected a loss of $0.66.

As expected, no revenue for the quarter ended March 31 was reported.

As of March 31, the company said it had $1.05 billion in cash and/or cash equivalents on hand, and expects it could be sufficient to fund operations through 2029.

The company's shares were up 1.7% in recent premarket activity on Tuesday.

Price: 20.83, Change: +0.36, Percent Change: +1.73